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Abstract: The interplay of metal oxide nanoparticles, environmental pollution, and health risks is
key to all industrial and drinking water treatment processes. In this work we present a study using
gel filtration chromatography for the analytical investigation of metal oxide nanoparticles in water,
their coating with polydopamine, and their encapsulation within lecithin liposomes. Polydopamine
prevents TiO2 and ZnO nanoparticles from aggregation during chromatographic separation. Lecithin
forms liposomes that encapsulate the nanoparticles and carry them through the gel filtration column,
producing an increase of peak area for quantitative analysis without any change in retention time to
affect qualitative identification. To the best of our knowledge, this is the first report that demonstrates
the potential application of lecithin liposomes for cleaning up metal oxide nanoparticles in water
treatment. Encapsulation of graphene quantum dots by liposomes would allow for monitoring of
nanoparticle-loaded liposomes to ensure their complete removal by membrane ultrafiltration from
treated water.
Keywords: encapsulation; gel filtration chromatography; fluorescence detection; lecithin; liposomes;
nanoparticles; polydopamine; titania; water treatment analysis; zinc oxide
1. Introduction
Nanomaterials exhibit novel physicochemical properties that continue to promote their use
in various industrial manufacturing processes. The top applications of nanomaterials in North
America includes catalysts, coatings, electronics, food products, paints, rubber tires, and textiles [1].
Three metal oxide nanoparticles having sizes between 1 and 100 nanometers, namely titania (TiO2),
zinc oxide (ZnO), and ceria (CeO2), are produced in high tonnage for use as additives in nanomaterials
worldwide. TiO2 nanoparticles are used as a fine whitener in cosmetics and sunscreen products
because of their brightness, high refractive index, and resistance to discoloration. However, concerns
are increasing recently about environmental pollution and the health risks of widespread exposure
to TiO2 nanoparticles. Long et al. reported that TiO2 nanoparticles can produce reactive oxygen
species that cause many diseases including immortalized brain microglia in mice [2,3]. Trouiller et al.
found that TiO2 nanoparticles are inducers of DNA damage and genetic instability in mice [4].
Chang et al. found a high percentage of biological toxicity when the liver and kidneys were exposed
to TiO2 nanoparticles [5]. Grande and Tucci lately discussed the potential human health risks
induced by exposure to TiO2 nanoparticles [6]. Disdier demonstrated that, despite a lack of brain
translocation, exposure to TiO2 nanoparticles induces blood-brain carrier physiology alteration and
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neuro-inflammation that may lead to central nervous system disorders [7]. Shah et al. have emphasized
the biological and chemical concerns about TiO2 nanoparticles as well as their toxicological profile at the
molecular level [8]. Water pollution has become a major concern for many countries in recent years due
to the rapid industrialization of nanotechnologies. Hence, the development of industrial wastewater
and drinking water treatment systems to remove TiO2 among other metal oxide nanoparticles is vital
to providing long-term environmental and public health security [9–11].
Polydopamine (PDA) is a multifunctional biopolymer structurally similar to naturally occurring
melanin [12]. PDA nanocapsules have been successfully used for drug delivery [13]. Their good
biocompatibility and biodegradability have facilitated biomedical development for use as both
a photoacoustic imaging contrast agent and a chemothermotherapy agent for tumors [14]. The high
wrapping tendency of PDA has favored the fabrication of Au-PDA nanoparticles with an ultrathin
(1.3 nm) shell for high sensitivity, uniformity, and stability in shell-isolated nanoparticle-enhanced
Raman spectroscopy [15]. A new magnetic molecularly imprinted polymer has been prepared
by polymerizing dopamine on the surface of Fe3O4 nanoparticles in the presence of thionine
template [16]. Novel ultrafiltration-adsorption membranes have been designed via decorating the
walls of membrane internal pores with PDA nanoparticles for removal of Pb2+, Cd2+ and Cu2+ [17].
A highly efficient nanofiltration membrane can be fabricated via surface decoration of metal-organic
framework/graphene oxide composite onto PDA-coated polysulfone substrate [18]. The PDA coating
can be dissolved in an alkaline solution to regenerate the membrane [19]. Dopamine can be added
to coat metal oxide nanoparticles under ultrasonication with PDA, which breaks up all coagulated
nanoparticles and prevents any re-aggregation to merit accurate analysis [20].
Lecithin, being a mixture of phospholipids, is the main component of lipid matrix in biological
membranes [21]. Crude lecithin is commercially available at a low cost in large quantities.
This natural zwitterionic surfactant can self-organize into lamellar Lα mesophase when small
amounts of water are admixed [22]. Liposomes of soy lecithin are readily prepared by strong
sonication [23], dehydration-rehydration-heating [24], and thin film ultrasonic dispersion [25,26]
to form an inner aqueous compartment surrounded by a concentric bilayer of phospholipids.
They are environmentally friendly and simple to manufacture at a high lipid concentration [27].
Microfluidization is more efficient than ultrasonication in particle size reduction [28]. As the lipid
bilayer membrane has an average particle size from 110 nm to 990 nm [29], they are a cost-effective
option for many applications to deliver drugs, imaging agents, peptides, proteins, and nucleic
acids [29–34]. Nano-liposomes of crude soy lecithin are also effective for cleaning fuel oil-contaminated
sands and soils [35]. The development of polymer-liposome complexes for biomedical applications
is growing rapidly [36,37]. A liposome—Ag-Au core/shell nanocomposite is good for drug delivery
by near infrared laser irradiation [38]. All these previous works contributed to our idea that lecithin
liposomes can readily encapsulate metal oxide nanoparticles.
Gel filtration chromatography (GFC) is a versatile analytical technique that permits the effective
separation of proteins and other biological molecules in an aqueous buffer solution [39]. Separation
is achieved using a porous gel matrix to which analyte molecules, for steric reasons, have different
degrees of access solely on the basis of molecular size [40]. Water is commonly used to pre-equilibrate
the gel-filtration matrix. The mechanism of size exclusion is also applicable for the separation
of nanoparticles after surface functionalization to improve their stability [41–44]. Unfortunately,
TiO2 nanoparticles form aggregates in aqueous suspension as a function of the electrolyte ionic strength
and nature of the divalent cations typically found in surface water and soil [45]. TiO2 nanoparticles
selectively adsorb water-soluble organic phosphates [46]. Lecithin at 5 µg/mL can stabilize these
nanoparticles [47]. Mesoporous carbon can be nano-emulsified in a lecithin O/W system to be trapped
in the pores of TiO2 for cosmetic applications [48].
In this work, GFC was used to investigate TiO2 and ZnO nanoparticles in water by fluorescence
detection, after coating them with PDA and encapsulating them within lecithin liposomes. It was
crucial to prevent aggregation of these nanoparticles in every water sample, to carry them through
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the gel filtration column without excessive retention, and to obtain reproducible detection peaks
during chromatographic separation. Potential applications for cleaning up metal oxide nanoparticles
during industrial wastewater and drinking water treatment are proposed. The idea of using lecithin
liposomes for nanoparticle pre-concentration and removal in water treatment analysis is innovative.
Its development into an industrial procedure is feasible as the reported critical micellar concentration of
lecithin is around 0.4 mg/mL and the assembled lecithin liposomes have a typical size of 100–1000 nm,
which is sufficient to accommodate all sizes of nanoparticles.
2. Materials and Methods
2.1. Materials
Methanol was purchased from VWR (Mississauga, ON, Canada). Soy lecithin in oil form was
obtained from Vita Health Products (Winnipeg, MB, Canada). Titanium dioxide nanopowder (21 nm
primary particle size), zinc oxide powder (maximum particle size: 45 nm), and Tris base (pKa = 8.2)
were obtained from Sigma-Aldrich (Oakville, ON, Canada).
2.2. Coating of TiO2 or ZnO Nanoparticles with Polydopamine
TiO2 or ZnO nanoparticles (100 mg), dopamine (100 mg), Tris (63 mg), and distilled deionized
water (60 mL) were mixed by magnetic stirring for 1 h. The mixture was centrifuged at 4500 rpm
for 30 min, the supernatant was discarded, and the TiO2-PDA or ZnO-PDA nanoparticles were
re-suspended in deionized water (40 mL) for all subsequent experiments.
2.3. Lecithin Liposomes Blank
A thick syringe needle was inserted to a capsule of lecithin oil for half an hour to suck lecithin
slowly into the syringe. A mixture of lecithin (0.05 mL) and methanol (4.95 mL) was sonicated by
an unbranded ultrasonic homogenizer (20 kHz, 108 W, sequentially powered on for 2 s, and powered
off for 5 s) for 5 min at room temperature to form a uniform dispersion. This dispersion was mixed
with distilled deionized water, obtained from a Millipore Milli-Q water system (Bedford, MA, USA),
at a ratio of 1:2 by volume to serve as a lecithin liposomes blank, for comparison with TiO2 or ZnO
nanoparticles encapsulated within lecithin liposomes, in GFC-FD analysis. In a mixture of methanol
and water (1:2 ratio), the dispersion of lecithin liposomes is stable for at least an hour, which was
enough time the GFC-FD analysis.
2.4. Lecithin Liposome-Encapsulated TiO2 or ZnO Nanoparticles
To prepare lecithin liposome-encapsulated TiO2 or ZnO nanoparticles, different concentrations
of nanoparticles (from 0.01 to 1.0 mg/mL prepared daily in our laboratory using distilled deionized
water as the dispersion medium) were mixed with the lecithin liposomes blank at a ratio of 2:1 by
volume. The mixtures were homogenized by the ultrasonic homogenizer (20 kHz, 108 W, sequentially
powered on for 2 s and powered off for 5 s) for 5 min at room temperature to form uniform suspensions
before GFC-FD analysis. Furthermore, different amounts (50–250 µL) of lecithin liposomes were added
to either distilled deionized water (500 µL) or 1.0 mg/mL TiO2 nanoparticles (500 µL), followed by
addition of distilled deionized water until the total volume was 750 µL.
2.5. UV-Visible Absorption and Fluorescence Emission Spectroscopy
Fluorescence excitation and emission spectra of samples were measured on a Horiba Jobin Yvon
(Edison, NJ, USA) FluoroMax-4 spectrofluorometer using a slit width of 4 nm for both emission and
excitation. First under excitation by UV light at a wavelength of 300 nm, the emission wavelength
was scanned from 350 to 550 nm to obtain a fluorescence emission spectrum. Next by monitoring the
emission intensity at a wavelength of 450 nm, the excitation wavelength was scanned from 200 to
400 nm to obtain a fluorescence excitation spectrum.
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2.6. Gel Filtration Chromatography
Gel filtration chromatography was performed on a Shimadzu LC-6A system (Columbia, MD,
USA), initially using a short column (Shodex SHSB-807G, 50 × 8 mm, 35 µm, MWCO 10,000) for rapid
analysis and eventually on a long column (Shodex SB-807HQ, 300× 8 mm, MWCO 10,000) for extended
analysis. Both columns were purchased from Canadian Life Science (Peterborough, ON, Canada).
Distilled deionized water was used as the mobile phase at a flow rate ranging from 0.3 mL/min to
1.0 mL/min. The GFC system was coupled to a Jasco FP-2020 Plus intelligent fluorescence detector
(Easton, MA, USA). Fluorescence detection (FD) employed λex = 365 nm and λem = 460 nm for
TiO2-PDA determination, or λex,max = 350 nm and λem,max = 395 nm for TiO2 determination.
3. Results and Discussion
Before GFC could be used to investigate the coating of TiO2 nanoparticles in water with PDA
and their encapsulation within lecithin liposomes, their fluorescence properties were studied in
order to determine the excitation and emission wavelengths for selective and sensitive detection.
Ultrasonic homogenization was evaluated for facilitating the encapsulation of TiO2-PDA nanoparticles
by lecithin liposomes, by observing if reproducible peaks could be obtained from GFC-FD analysis
for the chromatographic characterization of lecithin liposome-encapsulated TiO2-PDA nanoparticles.
A short GFC column was initially used for rapid analysis and a long column was used for extended
analysis to characterize their retention time, retention volume, and peak area at different flow rates of
the mobile phase. After the feasibility of determining TiO2 nanoparticles in the presence of lecithin
liposomes was confirmed, the potential application of lecithin liposomes for encapsulating other
metal oxide nanoparticles would be demonstrated with ZnO nanoparticles. Optimization of the new
method was carried out by adding different amounts of lecithin liposomes to a fixed concentration
of TiO2 nanoparticles. In order to develop a cost effective technology for the removal of metal oxide
nanoparticles in water treatment, graphene quantum dots were tested as a fluorescent sensor for
monitoring the complete removal of nanoparticle-loaded liposomes from the treated water.
3.1. Fluorescence Spectroscopy
The fluorescence property of lecithin liposome-encapsulated TiO2 nanoparticles was determined
first. The maximum excitation and emission wavelengths were measured to be λex,max = 350 nm
and λem,max = 395 nm in Figure 1a,a’. Next, λex = 365 nm and λem = 460 nm were determined for
lecithin-bound TiO2-PDA nanoparticles in Figure 1b,b’. Both excitation spectra look very similar
because lecithin liposomes are nearly transparent, the PDA coating is only a couple nanometers
thick, and TiO2 nanoparticles were mainly responsible for absorption of the UV light from 230 nm
to 400 nm. The two emission spectra are obviously different due to energy transfer from TiO2
nanoparticles emission at 395 nm to PDA emission at 460 nm in Figure 1b only. Efficient and facile
coating of TiO2 nanoparticles with PDA had previously been reported in the scientific literature [49,50].
The transmission electron microscopy images of TiO2 and TiO2-PDA nanoparticles in Figure 2 below
show how difficult it is to see their difference due to a thin organic PDA coating.
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Figure 1. Fluorescence excitation spectra using λem = 450 nm: (a) lecithin liposome-encapsulated TiO2
nanoparticles; and (b) lecithin liposome-encapsulated TiO2-PDA nanoparticles. Fluorescence emission
spectra using λex = 300 nm: (a’) lecithin liposome-encapsulated TiO2 nanoparticles; and (b’) lecithin
liposome-encapsulated TiO2-PDA nanoparticles.
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Figure 2. Transmission electron microscopy images: (a) TiO2 nanoparticles; and (b) TiO2-PDA
nanoparticles.
3.2. Rapid GFC-FD Analysis of Lecithin Liposome-Encapsulated TiO2–PDA Nanoparticles
A short GFC column (50 × 8 mm) was initially used for rapid analysis of lecithin liposome-
encapsulated TiO2-PDA nanoparticles. As expected, a PDA coating prevented the TiO2 nanoparticles
Separations 2018, 5, 13 6 of 19
from aggregation during chromatographic separation. Ultrasonic homogenization apparently
facilitated the encapsulation of TiO2 nanoparticles by lecithin liposomes, thus yielding reproducible
peaks for the chromatographic characterization of lecithin liposome-encapsulated TiO2-PDA
nanoparticles. The standard calibration curve in Figure 3 shows that the GFC-FD peak area increased
as the concentration of lecithin liposome-encapsulated TiO2-PDA nanoparticles increased. At the
lowest concentrations of lecithin liposome-encapsulated TiO2-PDA nanoparticles studied, peak areas
were very close to each other around the quantification limit of the GFC-FD analysis method. Next,
lecithin liposome-encapsulated PDA nanoparticles and PDA nanoparticles were also analyzed by
rapid GFC-FD for a comparison. Their peak areas in Figure 4b,c are significantly smaller than that in
Figure 4a despite equivalent concentrations. This difference in peak area can certainly be attributed
to the presence versus absence of TiO2 nanoparticles. A rapid method for the quantitative analysis
of TiO2-PDA nanoparticles by GFC-FD in 6 min is thus verified for the linear dynamic range from
0.05 mg/mL to 1.00 mg/mL.
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Figure 3. Standard calibration curve for rapid GFC analysis of lecithin liposome-encapsulated
TiO2-PDA nanoparticles, using λex = 365 nm and λem = 460 nm for FD.
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3.3. Rapid GFC-FD Analysis of Lecithin Liposome-Encapsulated TiO2 Nanoparticles
Lecithin liposome-encapsulated TiO2 nanoparticles (without PDA coating) were analyzed by rapid
GFC for elucidating the analytical merits of PDA. The peak area in Figure 5a was larger than that for
lecithin liposome-encapsulated TiO2-PDA nanoparticles in Figure 4a where the fluorescence from TiO2
nanoparticles was quenched by the PDA coating. Using next the maximum excitation and emission
wavelengths λex,max = 350 nm and λem,max = 395 nm for FD, a stronger peak was obtained for lecithin
liposome-encapsulated TiO2 nanoparticles in Figure 5b. A new standard calibration curve was constructed
in Figure 6 to validate the linear dynamic range from 0.05 mg/mL to 1.00 mg/mL. The maximum
wavelengths (λex,max = 350 nm and λem,max = 395 nm) generated a better calibration curve than the initial
wavelengths (λex = 365 nm and λem = 460 nm) in terms of sensitivity and linearity. These results indicate
the real possibility of determining lecithin liposome-encapsulated TiO2 nanoparticles down to 0.10 mg/mL.
Unfortunately, the blank (a mixture of lecithin liposomes and distilled deionized water in a ratio of 1:2
by volume) produced a peak area as large as those obtained from all standard concentrations below
0.10 mg/mL. This could probably be attributed to stronger fluorescence from the phosphatidylcholine and
phosphatidyl-ethanolamine contents of lecithin at these maximum wavelengths [51]. It became important
that the blank peak from lecithin liposomes be separated from the lecithin liposome-encapsulated TiO2
peaks by using a longer GFC column for extended analysis.
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(a)
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Figure 5. Rapid GFC analysis of (a) lecithin liposome-encapsulated TiO2 nanoparticles (1 mg/mL),
using (a) λex = 365 nm and λem = 460 nm; and (b) λex,max = 350 nm and λem,max = 395 nm, for FD.
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3.4. Extended GFC-FD Analysis of Lecithin Liposome-Encapsulated TiO2 Nanoparticles
A long GFC column (300 × 8 mm) was next used for extended analysis of lecithin liposome-
encapsulated TiO2 nanoparticles, TiO2 nanoparticles, and lecithin liposomes separately. It was
evidenced from the extended GFC-FD chromatograms (not shown here) that TiO2 nanoparticles
(injected at a low concentration of 0.01 mg/mL) were retained excessively on the long column as
no peak appeared using a mobile phase flow rate increasing from 0.5 mL/min up to 1.5 mL/min.
These results can be explained based on the time needed for water to wash the TiO2 nanoparticles
through the entire length of gel filtration matrix in the column. Fortunately, encapsulation of TiO2
nanoparticles within lecithin allowed them to go through the column together quickly to appear
as one combo peak at a retention time of 4.15 min. It was confirmed that the peak area of lecithin
liposome-encapsulated TiO2 nanoparticles was larger than that for lecithin liposomes alone, to our
great delight.
The influence of flow rate (from 0.5 to 1.0 mL/min) on the retention time, retention volume,
and peak area of lecithin liposome-encapsulated TiO2 nanoparticles (injected at a low concentration
of 0.01 mg/mL) was systematically investigated. An increase of flow rate obviously decreased their
retention time in Figure 7a, while the retention volume stayed constant at 4.03 ± 0.05 mL with a nearly
horizontal trend line in Figure 7b, and the peak area decreased in Figure 7c because the peak became
narrower as expected. The unidirectional trends of these results, within experimental errors, confirmed
consistently the feasibility of determining TiO2 nanoparticles in the presence of lecithin liposomes.
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Figure 7. Effects of flow rate on (a) retention time; (b) retention volume; and (c) peak area of lecithin
liposome-encapsulated TiO2 nanoparticles (0.01 mg/mL) in extend GFC analysis, using λex,max = 350 nm
and λem,max = 395 nm for FD.
The influen e of flow rat (from 0.3 to 1.5 mL/min) on the r tention time, retention volume,
and peak area of lecithin liposome-encapsulated TiO2 na op rticles (injected at a high concen ration
of 1.0 mg/mL) was also systematically investigated. An increase of flow r e again decreased their
retention time i Figure 8a while their rete ion volume remai ed constant at 3.95 ± 0.07 mL with
a ne rly horizontal tre line in Figure 8b. Interestingly, the retention vol m for lecithin liposomes
was actually higher, indicating a smaller size than lecithin liposome-encapsulated TiO2 nanoparticles.
This makes sense because the high concentration of encapsulated TiO2 nanoparticles could enlarge
the size of each and every lecithin liposome. As smaller molecules have greater access and larger
molecules are excluded from the gel filtration matrix, they would be eluted from the GFC column
in decreasing order of size. The difference in peak area between lecithin liposomes and lecithin
liposome-encapsulated TiO2 nanoparticles allowed easily for quantitative determination of TiO2
nanoparticles at this high concentration. Again, the peak area decreased in Figure 8c because the peak
became narrower as the flow rate was increased.
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Figure 8. Effects of flow rate on (a) retention times; (b) retention volumes; and (c) peak areas of lecithin
liposomes and lecithin liposome-encapsulated TiO2 nanoparticles (1.0 mg/mL) in extended GFC-FD
analysis, using λex,max = 350 nm and λem,max = 395 nm for FD.
The flow rate of 1.0 mL/min was deemed optimal for all subsequent extended GFC-FD
analyses of TiO2 (and other metal oxide) nanoparticles. Encapsulation within lecithin liposomes
improved their stability when travelling through the entire length of the gel filtration matrix in
the column. Lecithin liposomes apparently carried the TiO2 nanoparticles through the gel column,
as evidenced by a larger peak area, without increasing its original retention time—which indicated
a relatively large size corresponding to liposomes. Vemuri and Rhodes had previously explored
the use of size exclusion chrom togra hy, as a large-sc le proc s , to separate lipos mes from free
drug in a lipo om preparation [52]. I terestingly, lecithin presented no distinct critical micelle
concentrati n in either alcohol solutio or water suspension, as Hara et al. had measured using
electric conductivity and fluorescence [53]. Hypothetically, in the present work, TiO2 nanoparticles
were first stripped of all adsorbed anions by the methanol inside lecithin liposomes. Methanol had
previously been used for desorption of picrate anions from magnetic nanoparticles that were coated
with cetyltrimethyl-ammonium bromide [54]. Presumably, lecithin molecules dispersed around the
bare non-ionic TiO2 nanoparticles that interacted favorably with the hydrophobic lipid moiety of each
lecithin molecule. Under strong ultrasonication, they merged to form nanoliposomes, each containing
sever l TiO2 n n particles. Being metastable aggregates of lipids [55], coalescence between lecithin
nanoliposomes occurred when they wer compress d by ultr sonic homogenization [56]. A alibration
curve was constructed for the extended GFC analysis of lecithi -bound TiO2 nanoparticles at a flow
rate of 1.0 mL/min, using λex,max = 350 nm and λem,max = 395 nm for FD. As shown in Figure 9,
initially the GFC-FD peak area increased with increasing uptake of TiO2 nanoparticles by the lecithin
liposomes, up to 0.03 mg/mL. However, no significant increase in peak area could be observed from
0.03 to 0.06 mg/mL, apparently indicating no further uptake of TiO2 nanoparticles by the lecithin
liposomes. Above 0.06 mg/mL, the peak area continued to increase only moderately to suggest
a possible restructuring of the TiO2 nanoparticle-loaded lecithin liposo es. Further research needs to
elucidate the mechanism of action behind this irregular sha of the c libration curve.
Optimiz tion of the GFC-FD method was carried out by adding different amounts of lecithin
liposomes into either distilled deionized water or TiO2 nanoparticles (1.0 mg/mL). The peak area at
4.15 min for lecithin liposomes exhibited a linear correlation with the amount of lecithin liposomes as
shown in Figure 10. However, a significantly steeper slope was obtained for TiO2 nanoparticles (than
that for water). Apparently, the more lecithin liposomes were added, the lower the concentration of
TiO2 nanoparticles that would be encapsulated within each and every liposome. Thus, the excitation
of TiO2 fluorescence became more efficient and the emission of TiO2 fluorescence became less
self-quenched. This strongly suggested that more lecithin liposomes can be used to obtain a larger
peak area for any given concentration of TiO2 nanoparticles after subtraction of the lecithin liposomes
blank, thereby improving the analytical sensitivity of this extended GFC method.
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Figure 9. Standard calibration curve for extended GFC analysis of lecithin liposome-encapsulated TiO2
nanoparticles at a flow rate of 1 mL/min, using λex,max = 350 nm and λem,max = 395 nm for FD.
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Figure 10. Optimization of lecithin liposomes amount added to (a) distilled deionized water; and (b)
TiO2 nanoparticles (1.0 mg/mL), in extended GFC analysis using λex,max = 350 nm and λem,max = 395 nm
for FD.
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3.5. Extended GFC-FD Analysis of Lecithin Liposome-Encapsulated ZnO Nanoparticles
In order to demonstrate the potential application of lecithin liposomes for encapsulating metal
oxide nanoparticles other than just TiO2 in water treatment, extended GFC-FD analysis was next
performed on lecithin liposome-encapsulated ZnO nanoparticles, ZnO nanoparticles, and lecithin
liposomes. Just like TiO2, encapsulation of ZnO nanoparticles within lecithin liposomes allowed them
to go through the column together to appear as a combination peak at a retention time of 4.34 min in
Figure 11a. It was next evidenced that ZnO nanoparticles were strongly retained on the long column
until its peak appeared at 11.47 min in Figure 11b. The chromatogram in Figure 11c shows a peak
at 4.15 min with an area linearly proportional to the concentration of lecithin liposomes (R2 = 0.98,
data not shown). In hindsight, for the sake of contrasting, TiO2 nanoparticles had not shown any peak
and lecithin liposome-encapsulated TiO2 nanoparticles had exhibited a retention time of 4.42 min.
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Figure 11. Extended GFC analysis: (a) lecithin liposome-encapsulated ZnO nanoparticles (1.0 mg/mL);
(b) ZnO nanoparticles (1.0 mg/mL); and (c) lecithin liposomes, using λex = 350 nm and λe = 395 nm
for FD.
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The peak area of 1.0 mg/mL lecithin liposome-encapsulated ZnO nanoparticles was significantly
stronger than that of lecithin liposomes alone. A standard calibration curve has been constructed
in Figure 12 for the extended GFC analysis at a flow rate of 1.0 mL/min, using λex = 350 nm
and λem = 395 nm for FD. Binding of lecithin liposomes with ZnO nanoparticles is confirmed by
the larger peak areas for increasing concentrations from 0.01 mg/mL to 0.10 mg/mL. For lecithin
liposome-encapsulated ZnO nanoparticles, a detection limit of 0.05 mg/mL is attained by this
GFC-FD method.Separations 2018, 5, x FOR PEER REVIEW  14 of 19 
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Figure 12. Standard calibration curve for extended GFC analysis of lecithin liposome-bound ZnO
nanoparticles at a flow rate of 1 mL/min, using λex = 350 nm and λem = 395 nm for FD.
3.6. Extended GFC-FD Analysis of Lecithin Liposome-Encapsulated Graphene Quantum Dots
It is important to develop a cost effective technology for the removal of TiO2 nanoparticles ranging
from industri l wastewater to cont minated drinking water treatme t. A limiting fact in drinking
water treatmen is the ability to collect all the waterborne nanoparticles for removal. Industrial filtration
technologies re currently used on a very large scale but they are often plagued by tru tural variation
and surfac fouling of membrane filters [57–59]. The results discussed so far show the possibility
of using lecithin liposomes for simple water treatment. One monitoring requir ment is that the
nanoparticle-loaded lecithin liposomes must subsequently be removed from the treated water before
it is released to local waterways. Fluorescent GQDs have attracted tremendous attention for a wide
range of sensing applications because of their good water dispersibility, high photostability, excellent
biocompatibility, and low toxicity [60–62]. They can potentially serve as a sensor probe for monitoring
the complete removal of nanoparticle-loaded liposomes from the treated water. Extended GFC analysis
of a small aliquot of GQDs that had previously been synthesized and characterized in our lab [19]
produced a sharp FD peak at 21.2 min in Figure 13a, as expected for their small size of 5–6 nm. Extended
GFC analysis of GQDs in mixture with lecithin liposome-encapsulated TiO2 nanoparticles showed
a significant reduction in the GQDs peak area at 20.8 min and the appearance of a small peak at 9.4 min
in Figure 13b. This new peak could be attributed to the encapsulation of GQDs by lecithin liposomes
(loaded with TiO2 nanoparticles). This result is consistent with a previous work by Chen et al. on the
encapsulation of quantum dots in liposomes and the separation of nanoparticle-loaded liposomes from
unencapsulated nanoparticles by size exclusion chro atography using a Sepharose gel [63]. They used
flu resc nce correlation sp ctroscopy to determine th t each liposome encapsulated an averag of
three quantum dots. Hence, both studies have indicated GQDs can potentially serve the purpose of
Separations 2018, 5, 13 15 of 19
monitoring the nanoparticle-loaded liposomes to track their complete removal from treated water by
ultrafiltration using the membrane separation technology [19,64,65].Separations 2018, 5, x FOR PEER REVIEW  15 of 19 
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